Company Overview
About Reframe
Reframe (formerly Glucobit) is a San Francisco-based digital health platform — backed by Y Combinator (W21) — providing people seeking to quit or reduce alcohol consumption with a neuroscience-based mobile app that combines behavioral psychology, habit tracking, and community support, achieving $13 million in annual revenue with 150,000+ paying customers after 10x growth in 12 months and 3,000% growth in 6 months to become one of the top health apps on the App Store. Founded in 2018 by Ziyi Gao and Vedant Pradeep, Reframe raised $17.4 million in a Series B in January 2022 from Goodwater Capital, applying evidence-based alcohol reduction techniques (including CBT, mindfulness, and neuroscience education about alcohol's brain effects) to the 30 million Americans who want to drink less but don't seek traditional addiction treatment.
Business Model & Competitive Advantage
Reframe's alcohol reduction platform addresses the care gap between heavy drinking and formal addiction treatment: alcohol use disorder affects 29 million Americans, but only a fraction receive any treatment — most people who drink more than they want to exist in the "gray area" between social drinking and diagnosable addiction, and they don't seek AA, rehab, or clinical interventions because they don't identify as alcoholics. Reframe's non-stigmatizing, neuroscience-framed approach (explaining why alcohol creates cravings at a neurological level, providing daily science lessons about alcohol's health effects, and offering habit-building tools for identifying triggers and replacing drinking habits) meets gray-area drinkers where they are — providing structured support through the app without requiring clinical label or treatment program enrollment.
Competitive Landscape 2025–2026
In 2025, Reframe competes in the alcohol reduction apps, digital addiction support, and behavioral health market with Monument (online alcohol treatment, $22M raised), Ria Health (alcohol treatment app, $18M raised), and Tempest (sobriety platform, acquired by Monument) for consumer seeking alcohol moderation or sobriety digital health support platform adoption. Goodwater Capital's Series B investment reflects consumer digital health and behavior change app conviction. Y Combinator W21 backing connects Reframe with the digital therapeutics and mental health investor community. The 150,000+ paying subscribers at $13M ARR demonstrates the large addressable market in consumer alcohol reduction. The 2025 strategy focuses on employer benefit partnerships (alcohol misuse costs employers $250B annually in lost productivity), building the physician referral channel for clinical integration, and expanding the international market where alcohol reduction app adoption is growing in Europe and Australia.
Recent Activity
View all →Key Differentiators
Strong Challenger
Reframe is an established challenger with significant market presence and competitive offerings in Healthcare.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Epic Systems
Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Compare Reframe with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Reframe? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Reframe Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Reframe vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →